Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Davis, Lauren M G ^a   Martínez, Inés ^a   Walter, Jens ^a   Goin, Caitlin ^b   Hutkins, Robert W ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 16S; GALACTOSE OLIGOSACCHARIDE; PROBIOTIC AGENT; OLIGOSACCHARIDE; PREBIOTIC AGENT; RIBOSOME DNA;

ACTINOBACTERIA; ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTEROIDES; BIFIDOBACTERIUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA BARCODING; DNA SEQUENCE; FECES ANALYSIS; FECES MICROFLORA; FERMENTATION TECHNIQUE; FIRMICUTES; HIGH THROUGHPUT SEQUENCING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICROBIAL COMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION ABUNDANCE; PYROSEQUENCING; CLINICAL TRIAL; DRUG EFFECT; FECES; GASTROINTESTINAL TRACT; GENETICS; METHODOLOGY; MICROBIOLOGY;

ACTINOBACTERIA; BACTERIA (MICROORGANISMS); BACTEROIDES; BIFIDOBACTERIUM; FIRMICUTES;

BACTEROIDES; BIFIDOBACTERIUM; DNA, RIBOSOMAL; FECES; GASTROINTESTINAL TRACT; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; OLIGOSACCHARIDES; PREBIOTICS;

EID: 80053150201     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025200     Document Type: Article

References (52)

1. Pallen MJ, (2011) The Human microbiome and host-pathogen interactions. In: Nelson KE, editors. Metagenomics of the Human Body, Springer Science pp. 43-61.
2. Zhu B, Wang X, Li L, (2010) Human gut microbiome: the second genome of human body. Protein Cell 1: 718-725.
3. Gahan CGM, O'Sullivan GC, Collins JK, (2011) The Gut Microbiota, Probiotics and Infectious Disease. In: Malago JJ, editors. Probiotic Bacteria and Enteric Infections pp. 113-129.
4. Round JL, Mazmanian SK, (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9: 313-323.
5. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, et al. (2010) Specificity of polysaccharide use in intestinal Bacteroides species determines diet-induced microbiota alterations. Cell 141: 1241-1252.
6. Stecher B, Hardt WD, (2011) Mechanisms controlling pathogen colonization of the gut. Curr Opinion Microbiol 14: 82-91.
7. Cummings JH, Macfarlane GT, Macfarlane S, (2003) Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol 4: 9-20.
8. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT, (2004) Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38: 1690-1699.
9. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, et al. (2011) High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and noninflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11: 7.
10. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D, (2009) Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS ONE 4 (9): e7125.
11. Fava F, Lovegrove JA, Gitau R, Jackson KG, Tuohy KM, (2006) The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. Curr Med Chem 13: 3005-3021.
12. Ordovas JM, Mooser V, (2006) Metagenomics: the role of the microbiome in cardiovascular diseases. Curr Opin Lipidol 17: 157-161.
13. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480-484.
14. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5 (2): e9085.
15. Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, et al. (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10: 789-798.
16. Flint HJ, Duncan SH, Scott KP, Louis P, (2007) Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 9: 1101-1111.
17. Sears CL, Pardoll DM, (2011) Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. Infect Dis 203: 306-311.
18. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, et al. (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32: 815-827.
19. Kirjavainen PV, Arvola T, Salminen SJ, Isolaurie E, (2002) Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51: 51-55.
20. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, et al. (2004) The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans, a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80: 1658-1664.
21. Macfarlane GT, Steed H, Macfarlane S, (2008) Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104: 305-344.
22. Frank D, Pace N, (2008) Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenol 24: 4-10.
23. Ehrich SD, (2011) MetaHIT: The European Union Project on metagenomics of the human intestinal tract. In: editors. Metagenomics of the Human Body, Springer Science pp. 307-316.
24. Roberfroid M, (2007) Prebiotics: the concept revisited. J Nutr 137: 830S-837S.
25. Gibson GR, Probert HM, Van Loo J, Rastall RA, Roberfroid MB, (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17: 259-275.
26. Roberfroid MGR, Gibson L, Hoyles AL, McCartney R, Rastall I, et al. (2010) Prebiotic effects: metabolic and health benefits. Brit J Nutr 104 (Suppl 2): S1-63.
27. Davis LMG, Martínez I, Walter J, Hutkins R, (2010) A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol 144: 285-292.
28. Barrangou R, Altermann E, Hutkins R, Cano R, Klaenhammer TR, (2003) Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. Proc Natl Acad Sci USA 100: 8957-8962.
29. Barrangou R, Azcarate-Peril MA, Duong T, Conners SB, Kelly RM, et al. (2006) Global analysis of carbohydrate utilization by Lactobacillus acidophilus using cDNA microarrays. Proc Natl Acad Sci USA 103: 3816-3821.
30. Goh YJ, Lee JH, Hutkins RW, (2007) Functional analysis of the fructooligosaccharide utilization operon in Lactobacillus paracasei 1195. Appl Environ Microbiol 73: 5716-5724.
31. Saulnier DAA, Molenaar D, de Vos WA, Gibson GR, Kolida S, (2007) Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarrays. Appl Environ Microbiol 73: 1753-1765.
32. Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, et al. (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA 99: 14422-14427.
33. Sela D A, Chapman J, Adeuya A, Kim JH, Chen F, et al. (2008) The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci USA 105: 18964-18969.
34. Alles MS, Hartemink R, Meyboom S, Harryman JL, Van Laere KMJ, et al. (1999) Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on the putative risk markers for colon cancer. Am J Clin Nutr 69: 980-991.
35. Depeint F, Tzortzis G, Vulevic J, L'anson K, Gibson GR, (2008) Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 44171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 87: 785-791.
36. Ito M, Deguchi Y, Matsumoto K, Kimura M, Onodera N, et al. (1993) Influence of galactooligosaccharides on human fecal microflora. J Nutr Sci Vitaminol 39: 635-640.
37. Tannock GW, Munro K, Bibiloni R, Simon MA, Hargreaves P, et al. (2004) Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl Environ Microbiol 70: 2129-2136.
38. Apajalahti JHA, Kettunen H, Kettunen A, Holben WE, Nurminen PH, et al. (2002) Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl Environ Microbiol 68: 4986-4995.
39. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J, (2010) Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE 5 (11): e15046.
40. Martínez I, Wallace G, Zhang C, Legge R, Benson AK, et al. (2009) Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl Environ Microbiol 75: 4175-4184.
41. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, et al. (2009) The Ribosomal Database Project: improved alignments and new tools for rDNA analysis. Nucleic Acids Res 37: D141-D145.
42. Edgar RC, (2004) MUSCLE: multiple sequences alignment with high accuracy and high throughput. Nucleic Acids Res 32: 1792-1797.
43. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
44. Maukonen J, Mättö J, Kajander K, Mattila-Sandholm T, Saarela M, (2008) Diversity and temporal stability of fecal bacterial populations in elderly subjects consuming galacto-oligosaccharide containing prebiotic yoghurt. Int Dairy J 18: 386-395.
45. Duncan SH, Louis P, Thomson JM, Flint HJ, (2009) The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 11: 2112-2122.
46. Kneifel W, Rajal A, Kulbe KD, (2000) In vitro growth behaviour of probiotic bacteria in culture media with carbohydrates of prebiotic importance. Microb Ecol Health Dis 12: 27-34.
47. Mäkeläinen H, Saarinen M, Stowell J, Rautonen N, Ouwehand AC, (2010) Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures. Ben Microbes 1: 139-148.
48. MJ, Cummings JH, Macfarlane GT, (1998) Inter-species differences in maximum specific growth rates and cell yields of bifidobacteria cultured on oligosaccharides and other simple carbohydrate sources. J Appl Microbiol 85: 381-386.
49. Tzortzis G, Vulevic J, (2009) Galacto-Oligosaccharide Prebiotics. In: Charalampopoulos D, Rastall RA, editors. Prebiotics and Probiotics Science and Technology pp. 207-244.
50. Costabilea A, Kolidaa S, Klindera A, Gietla E, Bäuerleina M, et al. (2010) A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr 104: 1007-1017.
51. Kleessen B, Schwarz S, Boehm A, Fuhrmann H, Richter A, et al. (2007) Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr 98: 540-549.
52. Falony G, Calmeyn T, Leroy F, De Vuyst L, (2009) Coculture fermentations of Bifidobacterium species and Bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans. App Environ Microbiol 75: 2312-2319.